Scientists aim gene-targeting breakthrough against COVID-19
A team of scientists from Stanford University is working with researchers at the Molecular Foundry, a nanoscience user facility located at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab), to develop a gene-targeting, antiviral agent against COVID-19.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
More News: COVID-19 | Genetics | Laboratory Medicine | Legislation | Nanotechnology | Pharmaceuticals